The firm served as lead counsel for a national research university, asserting a constructive trust theory to protect the university's rights in an antiviral nucleoside analogue active against HIV and HBV, under circumstances in which a pharmaceutical company had filed a U.K. patent application for the drug at issue, without naming inventors.  The client's constructive trust claims survived summary judgment and the case settled on confidential terms, under which the client secured the intellectual property of its inventors.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Contract advice for Eltel Networks Infranet AB
Represented Eltel Networks Infranet AB, a leading European Infranet service company specializing in electricity and telecommunications networks, in more
Race discrimination class action for one of the largest U.S. forest product manufacturers
Represented one of the largest U.S. forest products manufacturers in a suit brought against our client in Alabama Federal court by the EEOC on behalf more
Patent litigation for global supplier of IT solutions for banks
The firm served as lead counsel on behalf of a global supplier of IT solutions for banks. Disc Link Corp. (“Disc Link”), a subsidiary of the patent more
Getty Properties Corp. v. Parmar
Represented Getty Petroleum Marketing Inc. in a case where a franchisee of the client was terminated he began using the Getty name in more